Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRWS Holdings Regulatory News (RWS)

Share Price Information for RWS Holdings (RWS)

Share Price is delayed by 15 minutes
Get Live Data
102.70    -0.30 (-0.29%)
Bid:
102.40
Ask:
102.70
Spread: 0.30 (0.293%)
Market Cap: £381.18m
RWS Live PriceLast checked at - London Stock Exchange

Intraday RWS Holdings Share Chart

Form 8 (OPD) - RWS Holdings plc

5 May 2022 15:05

RNS Number : 5092K
RWS Holdings PLC
05 May 2022
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

RWS Holdings plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

RWS Holdings plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

4 May 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

NIL

0

NIL

0

(2) Cash-settled derivatives:

 

NIL

0

NIL

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

NIL

0

NIL

0

 

TOTAL:

NIL

0

NIL

0

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

Shares held by the directors of RWS Holdings plc

Name

Number of Ordinary Shares of £0.01 each in the Offeree interested in

Percentage of total issued share capital (%) (excluding shares held in treasury) of the Offeree

Andrew Brode *

90,189,735

23.16

David Clayton

164,035

0.04

Ian El-Mokadem

75,000

0.02

Gordon Stuart

5,085

0.00

Lara Boro

5,050

0.00

 

*Shareholdings include those held by the Brode family and those disclosed by the Royal Bank of Canada, beneficially held by the trustee, RBC Trustees (Guernsey) Limited, via RNS announcement 1081J

 

Awards granted to the directors of RWS Holdings plc outstanding

Name

Description of Award

Date of Grant

Number of Ordinary Shares of £0.01 each subject to the outstanding awards

Option price

Vesting Date

Ian El-Mokadem

LTIP

24 January 2022

220,791

1p

24 January 2025

 

 

Shares held by Benson Street Limited (affiliate of Goldman Sachs International, a connected adviser of RWS Holdings plc)

Class of relevant security:

 

Ordinary

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0.00

0

0.00

(2) Cash-settled derivatives:

5,130

0.00

0

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

 

TOTAL:

5,130

0.00

0

0.00

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

5 May 2022

Contact name:

Christopher Lewey

Telephone number:

01753 480200

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEGZGGKDKGGZZM
Date   Source Headline
2nd Jun 202610:17 amRNSHolding(s) in Company
1st Jun 20267:00 amRNSTotal Voting Rights
5th May 202612:23 pmRNSUpdate re Agreement to acquire Obviously Group Ltd
5th May 20267:00 amRNSAgreement in principle to acquire Obviously Group
1st May 20267:00 amRNSTotal Voting Rights
28th Apr 202612:10 pmRNSHolding(s) in Company
27th Apr 20262:48 pmRNSHolding(s) in Company
23rd Apr 20267:00 amRNSTrading Statement
1st Apr 20267:00 amRNSTotal Voting Rights
26th Mar 20263:41 pmRNSDirector/PDMR Shareholding
25th Mar 20269:15 amRNS-RRWS launches Language Weaver Pro
25th Mar 20267:00 amRNSIssue of Equity and Total Voting Rights
10th Mar 20264:40 pmRNSHolding(s) in Company
10th Mar 20264:40 pmRNSHolding(s) in Company
4th Mar 20269:37 amRNSDirector/PDMR Shareholding
2nd Mar 20267:00 amRNSTotal Voting Rights
12th Feb 202611:45 amRNSDirector/PDMR Shareholding
11th Feb 202611:44 amRNSResult of AGM
11th Feb 20267:00 amRNSAGM Statement
10th Feb 20262:00 pmRNSHolding(s) in Company
6th Feb 202612:30 pmRNSDirector/PDMR Shareholding
2nd Feb 20267:00 amRNSTotal Voting Rights
30th Jan 20263:06 pmRNSHolding(s) in Company
28th Jan 20263:24 pmRNSDirector/PDMR Shareholding
28th Jan 20263:19 pmRNSDirector/PDMR Shareholding
23rd Jan 20261:00 pmRNSDirector/PDMR Shareholding
23rd Jan 20261:00 pmRNSDirector/PDMR Shareholding
23rd Jan 20269:00 amRNSOption Exercise, Admission and Total Voting Rights
23rd Jan 20267:00 amRNSHolding(s) in Company
14th Jan 20267:00 amRNSHolding(s) in Company
8th Jan 20269:00 amRNSPublication of Annual Report and Notice of AGM
2nd Jan 20264:51 pmRNSHolding(s) in Company
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
19th Dec 20257:00 amRNSHolding(s) in Company
19th Dec 20257:00 amRNSHolding(s) in Company
12th Dec 20253:53 pmRNSHolding(s) in Company
11th Dec 20257:01 amRNSDirectorate change
11th Dec 20257:00 amRNSFinal Results
1st Dec 20257:00 amRNSTotal Voting Rights
11th Nov 20258:00 amRNSHolding(s) in Company
7th Nov 20259:00 amRNSHolding(s) in Company
3rd Nov 20257:00 amRNSTotal Voting Rights
31st Oct 20259:00 amRNSHolding(s) in Company
28th Oct 20257:00 amRNSTrading Statement
20th Oct 20253:06 pmRNSHolding(s) in Company
20th Oct 20259:05 amRNS-RHead of Media & Entertainment appointment
15th Oct 20257:00 amRNSDirectorate Change
3rd Oct 20257:00 amRNSDirectorate Change
2nd Oct 202511:38 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.